Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine's Effects On Nicotine Response In Smokers
NCT02046551Phase 2Withdrawn
- Sponsor
- Yale University
- Start
- Apr 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atomoxetine in nicotine dependence, sponsored by Yale University. Planned start Apr 2014; status: withdrawn.
02
Drugs
atomoxetine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02046551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046551.